AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Semaglutide: From Diabetes Treatment to Weight Loss Wonder Drug
The chapter explores the drug Semaglutide, highlighting its potential 20% reduction in heart attack or stroke risk. It delves into its journey from a diabetes treatment to a popular weight loss drug, discussing the regulatory challenges in prescribing such medications in the UK NHS. The chapter also addresses concerns around prescribing drugs outside of licenses and the skepticism surrounding a study funded by Novo Nordisk, emphasizing the importance of further research for validation.